Back to Results
First PageMeta Content
Health / Sickle-cell disease / Anemia / Methadone / Hemoglobin / Medicine / Hematopathology / Chemistry


Phase 1 Clinical Trial Of The Candidate Anti-Sickling Agent Aes-103 In Adults With Sickle Cell Anemia Gregory J. Kato, MD, Marlene Peters Lawrence, RN, Laurel G. Mendelsohn, BS, Rehan Saiyed, BS, Xunde Wang, PhD, Anna K.
Add to Reading List

Document Date: 2013-12-19 11:36:38

Open Document

File Size: 377,13 KB

Share Result on Facebook

City

Newton / Rockville / /

Company

Aes / AesRx LLC / /

Currency

pence / /

Event

Judicial Event / FDA Phase / /

Facility

Blood Institute / /

IndustryTerm

Therapeutics for Rare and Neglected Diseases / /

MedicalCondition

pain / Sickle Cell Anemia Gregory J. Kato / sickle cell anemia / /

Organization

Branch / National Heart / Lung / and Blood Institute / National Center / /

Person

George Grimes / Gregory J. Kato / Caterina P. Minniti / Xunde Wang / Anna K. Conrey / John McKew / Marlene Peters Lawrence / Rehan Saiyed / Laurel G. Mendelsohn / James G. Taylor / Warren Stern / /

Product

hydroxyurea / Aes103 / Aes / /

ProvinceOrState

Maryland / Massachusetts / /

Technology

pharmacokinetics / polymerization / /

SocialTag